Charles B. O'Keeffe

Director, Catalyst Pharmaceuticals.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 14, 2025Exercised options 4,000 shares of Catalyst Pharmaceuticals²
Dec 27, 2024Exercised options 1,333 shares of Catalyst Pharmaceuticals³
Dec 10, 2024Exercised options 40,000 shares at $4.01 of Catalyst Pharmaceuticals⁴
Dec 9, 2024Exercised options 1,413 shares of Catalyst Pharmaceuticals⁴
Feb 15, 2024Exercised options 4,000 shares of Catalyst Pharmaceuticals⁵
Jan 2, 2024Exercised options 60,000 shares at $1.13 of Catalyst Pharmaceuticals⁶
Dec 27, 2023Exercised options 1,333 shares of Catalyst Pharmaceuticals⁷
Feb 15, 2023Exercised options 4,000 shares of Catalyst Pharmaceuticals⁸
Jan 24, 2023Exercised options 50,000 shares at $0.79 of Catalyst Pharmaceuticals⁹
Dec 6, 2022Exercised options 1,334 shares of Catalyst Pharmaceuticals¹⁰
Nov 15, 2022Sold 87,985 shares at $16.04 of Catalyst Pharmaceuticals¹¹
Aug 18, 2022Exercised options 40,000 shares at $2.53 of Catalyst Pharmaceuticals¹²
Dec 3, 2021Exercised options 1,333 shares of Catalyst Pharmaceuticals¹³

The numbers on this page point here. Each one links to the record it came from.